fda semaglutide approval The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing U.S. FDA finds no evidence

Europe Middle East and Africa Kingdom of Saudi Arabia United Arab Emirates South Africa Rest of Middle East and Africa - Frequently Asked Questions - How large is the demand for GLP-1 Companion Products in the global market in 2025

When administered just 30 seconds after a 20-minute ischemic event, BPC-157 significantly reduced neuronal damage

The tirzepatide before and after data shows similar threshold effects at the 15% mark, reinforcing that this is a physiologically meaningful breakpoint across compound classes

Reishi, often referred to as the "Mushroom of Immortality," is prized for its ability to reduce stress and promote relaxation